Daniel Swisher
Chairman bij CERUS CORPORATION
Vermogen: 7 M $ op 29-02-2024
Profiel
De heer Daniel N. Swisher is President & Chief Operating Officer bij Jazz Pharmaceuticals Plc., President & Chief Operating Officer bij Jazz Pharmaceuticals, Inc., Onafhankelijk Bestuurder bij Corcept Therapeutics, Inc. en Voorzitter bij Cerus Corp. Hij zit in de Raad van Bestuur van Corcept Therapeutics, Inc. De heer Swisher was voorheen werkzaam als President, CEO, Secretaris & Bestuurder bij Sunesis Pharmaceuticals, Inc. en als Senior Vice President-Sales & Marketing bij ALZA Corp. Hij behaalde zijn doctoraal aan de Yale University en een MBA aan de Stanford Graduate School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-05-2023 | 55 014 ( 0.09% ) | 7 M $ | 29-02-2024 | |
CERUS CORPORATION
0.06% | 07-06-2023 | 104 545 ( 0.06% ) | 227 908 $ | 29-02-2024 |
26-10-2023 | 0 ( -.--% ) | - $ | 29-02-2024 | |
01-03-2024 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Daniel Swisher
Bedrijven | Functie | Begin |
---|---|---|
CERUS CORPORATION | Chairman | 01-10-2013 |
CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 18-06-2015 |
PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 26-10-2023 |
Eerdere bekende functies van Daniel Swisher
Bedrijven | Functie | Einde |
---|---|---|
JAZZ PHARMACEUTICALS PLC | President | 01-10-2023 |
VIRACTA THERAPEUTICS, INC. | Chief Executive Officer | 31-12-2017 |
ALZA CORPORATION | Sales & Marketing | 01-09-2001 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | President | - |
Opleiding van Daniel Swisher
Yale University | Undergraduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
CERUS CORPORATION | Health Technology |
CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |